venlafaxine hydrochloride and Hypertension

Topics: Animals; Antidepressive Agents; Bupropion; Cardiovascular Diseases; Cardiovascular System; Cyclohexanols; Humans; Hypertension; Patents as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

Topics: Depressive Disorder; Dose-Response Relationship, Drug; Drug Overdose; Female; Humans; Hypertension; Long QT Syndrome; Pre-Eclampsia; Pregnancy; Serotonin and Noradrenaline Reuptake Inhibitors; Torsades de Pointes; Venlafaxine Hydrochloride

Topics: Adult; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Dizziness; Double-Blind Method; Female; Fluoxetine; Gastrointestinal Diseases; Headache; Humans; Hypertension; Male; Middle Aged; Respiratory Tract Infections; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride

Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Heart Conduction System; Humans; Hypertension; Hypotension, Orthostatic; Incidence; Placebos; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Blood Pressure; Cyclohexanols; Depressive Disorder; Diastole; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Incidence; Male; Middle Aged; Posture; Proportional Hazards Models; Regression Analysis; Venlafaxine Hydrochloride

Topics: Accidental Falls; Aged; Aged, 80 and over; Blood Pressure; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Hypertension; Hypotension, Orthostatic; Male; Middle Aged; Prospective Studies; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride

Topics: Age of Onset; Aged; Arrhythmias, Cardiac; Cardiovascular Diseases; Cognition Disorders; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Drug Monitoring; Electrocardiography; Female; Guidelines as Topic; Heart Rate; Humans; Hypertension; Hypotension, Orthostatic; Male; Neuropsychological Tests; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tachycardia; Venlafaxine Hydrochloride

Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Dizziness; Double-Blind Method; Female; Fluoxetine; Gastrointestinal Diseases; Headache; Humans; Hypertension; Male; Middle Aged; Respiratory Tract Infections; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride

Topics: Amlodipine; Antihypertensive Agents; Cytochrome P-450 CYP2D6 Inhibitors; Databases, Factual; Drug Interactions; Drug Prescriptions; Female; Humans; Hypertension; Male; Ramipril; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride

Topics: Antidepressive Agents, Second-Generation; Catatonia; Cyclohexanols; Female; Humans; Hypertension; Hyponatremia; Middle Aged; Venlafaxine Hydrochloride

Topics: Aged; Cataplexy; Cyclohexanols; Electroencephalography; Female; Humans; Hypertension; Narcolepsy; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride

Topics: Age Factors; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cohort Studies; Comorbidity; Cyclohexanols; Drug Interactions; Female; Heart Failure; Humans; Hypertension; Male; Myocardial Infarction; Ontario; Retrospective Studies; Risk Factors; Sertraline; Tachycardia; Venlafaxine Hydrochloride

Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Differential; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Ischemic Attack, Transient; Retreatment; Stroke; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride

Topics: Aged; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Atenolol; Combined Modality Therapy; Cyclohexanols; Depression; Electroconvulsive Therapy; Fatal Outcome; Female; Humans; Hypertension; Venlafaxine Hydrochloride

Topics: Age Factors; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Comorbidity; Cyclohexanols; Depression; Diabetes Mellitus; Fee-for-Service Plans; Female; Health Status; Heart Diseases; Humans; Hypertension; Male; Medicare; Monoamine Oxidase Inhibitors; Multivariate Analysis; Racial Groups; Sample Size; Sampling Studies; Selective Serotonin Reuptake Inhibitors; Sex Factors; Socioeconomic Factors; Venlafaxine Hydrochloride

Topics: Adult; Alcohol Deterrents; Alcoholism; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depression; Disulfiram; Drug Interactions; Humans; Hypertension; Venlafaxine Hydrochloride

Topics: Adult; Aged; Blood Pressure; Cyclohexanols; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Formularies as Topic; Humans; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing; United Kingdom; Venlafaxine Hydrochloride

Topics: Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Cyclohexanols; Female; Humans; Hypertension; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride

Topics: Antidepressive Agents, Second-Generation; Blood Pressure; Cyclohexanols; Depression; Drug Administration Schedule; Humans; Hypertension; Nausea; Selective Serotonin Reuptake Inhibitors; Therapeutic Equivalency; Venlafaxine Hydrochloride

Topics: Adult; Anti-Arrhythmia Agents; Cardiomyopathies; Chest Pain; Cyclohexanols; Electrocardiography; Heart; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tachycardia, Sinus; Venlafaxine Hydrochloride; Ventricular Function, Left